SPN interviews Drs. Michael Dixon and James Linder of UNeMed
After hearing information about the exciting things happening at UNeMed Corporation we were able to align an interview with Drs. Michael Dixon and James Linder and learn more about UNeMed as well as what is in the works.
If you recall, the last Creative Capital Pitch Session winner, Habitwise, was a product that spun out of development at UNeMed. We'll have more information on Habitwise in the near future...
Here's the About Us from UNeMed's website:
UNeMed is focused on developing and fostering relationships with industry to transfer UNMC intellectual property from the academic laboratory to the marketplace. Consistent with its focus, UNeMed continues to seek industrial licensing opportunities to enhance the development of its technologies and foster scientific breakthroughs at UNMC.
Established in 1991, UNeMed is the technology transfer leader for the University of Nebraska Medical Center. UNeMed has a diverse technology portfolio that addresses significant medical and clinical needs in areas such as Therapeutics, Diagnostics, Medical Devices, Research Tools and Software.
UNeMed fosters and commercializes innovation at UNMC. Our employees work with the UNMC community to advance research and healthcare for the economic benefit of the University of Nebraska.
Some facts I found interesting about UNeMed are that they currently offer a portfolio of over 100 technologies which are available for licensing and the team works through roughly 300 contracts each year enabling research and additional collaboration at UNMC. A lot of exciting work and innovation taking place that is continuing to put our region on the map nationally.
Enjoy the interview with UNeMed and you can contact them with questions at email@example.com or by calling (402) 559-2468.